Massachusetts Financial Services
RIGL icon

Massachusetts Financial Services’s Rigel Pharmaceuticals RIGL Stock Holding History

Massachusetts Financial Services’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Sell
42,341
-1,688
-4% -$52.1K ﹤0.01% 846
2026
Q1 		$1.19M Sell
44,029
-8,953
-17% -$301K ﹤0.01% 835
2025
Q4 		$2.27M Sell
52,982
-1,752
-3% -$66K ﹤0.01% 780
2025
Q3 		$1.55M Buy
54,734
+3,601
+7% +$108K ﹤0.01% 779
2025
Q2 		$958K Buy
51,133
+17,764
+53% +$337K ﹤0.01% 812
2025
Q1 		$600K Buy
+33,369
New +$677K ﹤0.01% 839

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Massachusetts Financial Services's RIGL Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Rigel Pharmaceuticals (RIGL) stake by 3.8% in Q2 2026, selling an estimated $52.1K and leaving 42,341 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Massachusetts Financial Services first reported a position in RIGL in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.27M in Q4 2025. 46 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Massachusetts Financial Services held 42,341 shares of Rigel Pharmaceuticals worth $1.66M as of Q2 2026.
  • Massachusetts Financial Services sold 1,688 Rigel Pharmaceuticals shares in Q2 2026, an estimated $52.1K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #846 holding.
  • Massachusetts Financial Services first reported a position in Rigel Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Massachusetts Financial Services's Rigel Pharmaceuticals position peaked at $2.27M in Q4 2025.
  • 46 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.